Graphical Abstract Highlights
INTRODUCTION
Clinical studies show that physical exercise protects against brain atrophy and reduces the risk of dementia, as well as promoting cerebral and cardiovascular health (Barnes, 2015) . The protective effect of exercise is also being recognized as a means to enhance cognitive function and slow down neurodegenerative disease progression and disability (Erickson et al., 2011; Pereira et al., 2007) . Indeed, rodent studies have confirmed that exercise regimens improve motor and cognitive functions in a variety of neurodegenerative models including stroke, Parkinson's disease, Alzheimer's disease, spinocerebellar ataxia, and multiple sclerosis (Abbott et al., 2004; Colcombe et al., 2004; Cruise et al., 2011; Fryer et al., 2011; Heyn et al., 2004; Khalil et al., 2013; Verghese et al., 2003) . Despite these advances, our understanding of the molecular mechanisms by which exercise impedes or protects from neurodegeneration remains poorly understood.
Physical exercise increases skeletal muscle metabolism by enhanced contractile and epinephrine activity that drive adaptive responses to alter whole body energy and glucose homeostasis. Among these responses is the secretion of autocrine and paracrine factors from the muscle, collectively called myokines. These include IL-6, IL-15, IGF-1, and brain-derived growth factor (BDNF), whose functions are to increase appetite, improve mood, increase mitochondrial oxidative phosphorylation, and enhance overall metabolic efficiency (Pedersen and Febbraio, 2012) . Of these, BDNF has an impact on brain function with several studies demonstrating that exercise promotes the generation of new neurons within the hippocampus, improves memory, and improves performance in aged mice (van Praag et al., 1999a (van Praag et al., , 1999b (van Praag et al., , 2005 . Similarly, the neuropeptide precursor VGF (non-acronymic; also known as nerve growth factor inducible; unrelated to VEGF) is also upregulated upon exercise and promotes an anti-depressant response (Hunsberger et al., 2007) . Other studies suggest that VGFprocessed peptides function to maintain BDNF expression in a VGF-BDNF-positive feedback loop (Alder et al., 2003; Bozdagi et al., 2008; Hunsberger et al., 2007) . However, the importance of VGF to delaying or preventing neurodegeneration remains obscure.
Although significant attention has focused on the idea that exercise promotes the activation of neurogenesis, recent papers suggest that oligodendrogenesis is also a significant contributor to brain repair and the maintenance of brain health. Recent studies have shown that neuronal activity promotes oligodendrogenesis and adaptive myelination in complex learning tasks or following demyelination injury (Brousse et al., 2015; Gautier et al., 2015; Gibson et al., 2014) . Voluntary exercise also increased oligodendrogenesis in the spinal cord of nestin-GFP transgenic mice (Krityakiarana et al., 2010) . Other studies show that injury results in massive recruitment of cells from the subventricular zone (SVZ) that adopt an oligodendrocytic fate, whereas another study showed that de novo synapse formation onto OPCs resulted in glutamate-induced differentiation of oligodendrocytes to facilitate remyelination (Brousse et al., 2015; Gautier et al., 2015) . Similarly, Piao et al. (2015) demonstrated that engrafted OPCs derived from human ESCs could facilitate forebrain and cerebellar remyelination, which functionally improved cognitive and motor deficits of irradiated animals. Despite these exciting findings, the molecular pathways driving recovery of these pathological states require further investigation. Nonetheless, manipulating levels of OPC genes, including Olig2, Sox2, or TAPP1 have been shown to influence OPC recruitment and/or myelination thereby inferring the importance of external signaling pathways on this process, such as those induced by exercise (Chen et al., 2015; Wegener et al., 2015; Zhao et al., 2015) .
Recently, we characterized mice inactivated for the Snf2h gene demonstrating that these animals have cerebellar hypoplasia, develop severe ataxia by postnatal day 20 (P20), and die between P25-P45 (Alvarez-Saavedra et al., 2014) . At the cellular level, these mice generate significantly fewer granule and Purkinje cells (PC) within the cerebellum, accompanied by poor PC dendritic arborization. Molecularly, alterations in chromatin folding underlie the progressive death of surviving neurons. In this study, we assessed whether our model was receptive to exercise therapy and could be used to identify molecules and/or novel pathways that delayed the progression of this neurodegenerative phenotype. Here, we present evidence to suggest that the long-term survival of these mice is attained through voluntary exercise. Exercise induced the myelination of cerebellar neurons, amelioration of motor deficits and a significant extension of lifespan that was dependent on continued exercise or adenoviral-mediated VGF overexpression.
RESULTS

Voluntary Running Extends the Lifespan of Snf2h cKO Mice
To investigate the mechanisms linking exercise to neural protection, we made use of mice ablated for the chromatin remodeler Snf2h in the brain that develop a progressive neurodegenerative and ataxic phenotype (Alvarez-Saavedra et al., 2014) . Conditional Snf2h-null mice have an abnormal gait with reduced weight gain by postnatal day 10 (P10), that progresses to classical signs of cerebellar ataxia by P20. Mice perform poorly in motor function tests at this age, continue to physically degenerate, show progressive Purkinje cell (PC) loss, and die between P25-P45 (Alvarez-Saavedra et al., 2014) . Morphologically, the cerebellum of Snf2h cKO mice is one-third the size of control littermates due to a severe reduction in granule neuron progenitor expansion, coupled with the progressive death of PCs (AlvarezSaavedra et al., 2014) . Given the progressive nature of the phenotype and the collective finding that exercise can improve neurodegenerative disorders, we reasoned that the Snf2h cKO mice would be a good model to further examine the underlying mechanisms involved. To assess whether our model was receptive to exercise therapy, we provided them with unlimited access to a running wheel shortly after weaning ($P21-P23). Strikingly, voluntary running prolonged the survival of Snf2h cKO animals beyond 1 year of age ( Figure 1A ). Running was critical for longterm survival as a cohort of mice that received the running wheel at P21-P25 but had it removed at P100 showed a progressive decline and death between P150-P200 ( Figure 1A ). Along with survival, running increased weight gain in Snf2h cKO mice at a rate that was similar to wild-type littermate controls ( Figure 1B ). Snf2h cKO mice showed daily improvement in the distance traveled but overall averaged one-half the total traveled distance of control littermates ( Figure 1C ). Previously, we demonstrated that the Snf2h cKO mice have motor deficits, as they fell much quicker from either a small elevated platform or when placed on a rotarod, a rotating rod that increases in speed with time (Alvarez-Saavedra et al., 2014) . As such, we repeated these assays with Snf2h cKO runner mice. Running improved performance in the rotarod assay ( Figure 1D ) and open field tests ( Figures 1E-1G ). Moreover, Snf2h cKO mice tested in the elevated platform and rotarod assays 50 days post-wheel removal displayed diminished performance compared to mice that continued to run (Figures 1H and 1I ; Movies S1, S2, S3, S4, S5, S6, S7, and S8).
Voluntary Running Triggers Oligodendrogenesis, Myelination, and PC Dendritic Arborization of the Ataxic Cerebellum Because physical exercise can trigger both neurogenesis and oligodendrogenesis in the murine forebrain (Krityakiarana et al., 2010; van Praag et al., 1999a) , we next determined which process was active in hindbrain areas. Bromodeoxyuridine (BrdU) was administered via the drinking water (2 g/L) to label dividing cells between P21-P35 in wild-type controls (hereon referred to as WT) and Snf2h cKO mice (cKO hereon) provided with running wheels at P21. Whole brain sagittal sections through the deep cerebellar nuclei (DCN) of the cerebellum and the inferior olivary nucleus within the brain stem (also known as inferior olive), a major site of input into the cerebellum, were then analyzed either 55 or 145 days post-BrdU administration (P90 or 180, respectively) for BrdU + cells co-stained with the oligodendrocyte precursor (OP) or oligodendrocyte (OL) markers NG2 and Olig2, respectively. As expected, we observed prominent BrdU-labeling within the hippocampus in WT-Runner and cKO-Runner mice relative to sedentary controls ( Figure S1 ). We did not detect any BrdU-labeled PCs in the cerebellum of any genotype (data not shown). However, cKO-Runner mice showed increased BrdU + /NG2 + cell numbers within the cerebellum and the brain stem (Figures 2A-2C , S2, and S3), suggesting that oligodendrogenesis may partially underlie the long-term recovery of ataxic exercising mice. Indeed, BrdU-retaining cells that co-expressed the differentiated OL marker Olig2 were significantly upregulated in cKO-Runners at P90 and P180 relative to all controls in both the cerebellum and inferior olive ( Figure 2D ). We additionally attempted to block oligodendrogenesis by administering 10 mg/kg trichostatin A (TSA) at P30, as has been recently described (Gibson et al., 2014) , and co-administered EdU the following day for 3 consecutive days at 100 mg/kg. Cerebella were analyzed at P40 with double labeling for EdU and NG2, but we did not observe a significant decrease on the number of NG2 + /EdU + cells in the cerebella of Snf2h cKO-Runner mice with TSA or vehicle treatment ( Figure S4 ). Because neurodegenerative pathologies are also associated with increased inflammation (Fernandes et al., 2014; Skaper, 2007) , we assessed the total number of Iba1 + microglia or GFAP + astrocytes within the cerebellum and inferior olive from all genotypes. This experiment revealed no changes in the total number of either Iba + or GFAP + cells ( Figures 2E and 2F ).
To assess whether the increased number of Ng2 + and Olig2 + OPs and OLs resulted in increased myelination, toluidine (A) Kaplan-Meier curve for Snf2h cKO (cKO hereon) mice in sedentary (cKO-Sedentary; black) or running conditions (cKO-Runner) with wheels introduced at P21 and never removed (blue); or wheels removed at P100 (cKO-Runner, wheels out; red). Control sedentary and Control Runner mice were also included, but they're masked by the blue line. Analysis was terminated at 1 year of age (P365). n = 6-10 mice per condition. (B) Total body weight of cKO-Runner or Control-Runner littermates with wheels introduced at P25. n = 8, males only. Error bars represent ± SEM. *p < 0.05, n.s., non-significant, n = 6-8 mice per condition. (C) Total kilometers traveled for 20 days after wheels were introduced at P25. n = 8, males only. *p < 0.05, **p < 0.01, n.s., non-significant. (D) Rotarod analysis for CT-Runner, cKO-Sedentary, and cKO-Runner mice for 2 consecutive days 15 days post-running (wheels in at P25). Note that CT-Sedentary mice behave identical to CT-Runner mice. *p < 0.05, n = 6-8 mice per condition.
(E-G) Open field assay for CT-Runner, cKO-Sedentary, and cKO-Runner mice 15 days post-running (wheels in at P25). Time in all corners (E), total distance traveled (F), and velocity (G) was averaged from 6-8 mice per genotype. *p < 0.05, **p < 0.01. (H and I) Elevated platform (H) and rotarod assays (I) at P125 from WT-Sedentary, cKO-Sedentary, cKO-Runner, and cKO-Runner-wheels out mice (wheels in at P21-P25, wheels out at P75). *p < 0.05, **p < 0.01, n = 6-8 mice per condition. See also Movies S1, S2, S3, S4, S5, S6, S7, and S8.
blue-stained and ultrathin transmission electron microscopy (TEM) images from the molecular layer and the white matter of the cerebellum were obtained from WT and cKO mice 125 days post-running (wheels introduced at P25) and from P25 WT and cKO sedentary mice as controls. Strikingly, we observed myelin rings surrounding most PCs in cKO-Runner mice that were not present in WT-Sedentary, WT-Runner, or cKO-Sedentary mice ( Figures 3A, 3B , and S5A-S5C). As control, the white matter of the cerebellar lobes from all genotypes showed comparable myelination ( Figure 3A , rightmost panels), as well as the sciatic nerves ( Figure S5D ). Myelination is not typically present within the molecular layer of the cerebellum and due to the disorganization of the mutant cerebellum, we were unable to determine if the myelination was present on axons of PCs projecting from a different plane, or derived from the parallel and climbing fibers of granule or inferior olivary neurons, respectively. Regardless, we speculated that increased myelination protects and strengthens the function of the existing neurons in the cerebellum of mutant mice. Because increased myelination confers improved neuronal function and because running activity was shown to improve PC dendritic arborization (Fernandes et al., 2014) , we next examined the thickness of the molecular layer. Indeed, we observed a significant increase in the thickness of the molecular layer in both WT-Runner and cKO-Runner mice versus WT-Sedentary and cKO-Sedentary animals ( Figures 4A-4D ). These results are further supported as increased PC dendritic growth has been previously attributed to running activity in wild-type rodents (Pysh and Weiss, 1979) . To further attribute this to a neuronal effect, we co-labeled WT and cKO Sedentary or Running (15 days post running; wheels in at P25) mice with the serotonin transporter (Slc4a6) and Calbindin, a marker of PCs. We observed increased Slc4a6 puncta within the PC soma of cKO-R mice relative to all control genotypes, suggesting that running enhanced the activity and survival of existing mutant PCs ( Figure 4E ). As an additional control, we performed histology on the transverse abdominal (TA) muscle of control and Snf2h cKO sedentary and runner mice revealing no major structural differences among genotypes and conditions ( Figure S6 ).
Comparative RNA Sequencing Analysis Identified Increased Levels of the VGF Neuropeptide Concomitant to our cellular studies, we performed RNAsequencing (RNA-seq) experiments to identify potential molecular correlates contributing to the exercise-induced rescue of cKO mice. While we recognize that some gene expression changes may arise from differences in certain cell types in the mutant cerebellum (i.e., reduced granule neurons), it provides a useful starting point to initiate molecular studies. We performed a four-way comparative analysis between samples sequenced from WT-Sedentary, WT-Runner, cKOSedentary, and cKO-Runner cerebella, identifying 2,290 upregulated and 1,321 downregulated genes in the cKO-R versus WT-R analysis ( Figure 5 ; see Data S1 for complete gene lists). Gene Ontology (GO) analyses were consistent with our findings, namely that genes involved in neurotransmitter release and activity-dependent synaptic transmission (e. Figure 6A ). In addition, we observed an increase in growth factors (e.g., Dlk1 and Tdgf1) and the exercise-induced neuropeptide precursor protein VGF ( Figure 6B ) (Hunsberger et al., 2007 Figure 6B ). Lastly, we found that the VGF precursor protein is robustly and significantly upregulated in cerebella of Snf2h cKO-Runner mice relative to Snf2h cKOSedentary, Control-Sedentary, and Control-Runner mice after 15 days of running (wheels in at P25, analysis at P40; Figure 6C ).
VGF Promotes the Proliferation and Differentiation of OP Cultures
The upregulation of the VGF gene was of particular interest because it was reported to be highly expressed in OPs (Dugas et al., 2006) . Furthermore, its upregulation upon exercise activates the anti-depressant response in mammals and maintains BDNF expression in a VGF-BDNF-positive feedback loop (Alder et al., 2003; Bozdagi et al., 2008; Hunsberger et al., 2007) . Moreover, reduced VGF peptide levels are considered biomarkers for both amyotrophic lateral sclerosis (ALS) and Alzheimer's disease, pathologies that have a demyelination component (Pasinetti et al., 2006; Selle et al., 2005) . Hence, we next asked whether VGF peptides could stimulate the growth and/or differentiation of homogenous preparations of primary cortical mouse OPs (O'Meara et al., 2011) . VGF is cleaved to produce numerous C-terminal bioactive peptides including TLQP-62, TLQP-21, and AQEE-30, among others (Lewis et al., 2015) . As such, we treated OP cultures with previously characterized peptides that trigger BDNF production TLQP-21 (3 mM), AQEE-30 (3 mM), BDNF (50 ng/mL), or DMSO In contrast, no significant differences were observed in any of the other treatments ( Figure 7A ). We next assessed differentiation of the cultures with the mature OL markers myelin-associated glycoprotein (MAG) and myelin basic protein (MBP), where we observed that TLQP-21 also increased the average oligodendrocyte dendritic length suggesting that this VGF peptide can promote both OP proliferation and their subsequent differentiation into OLs (Figures 7B and 7C) . Indeed, VGF protein levels are robust early in the OP differentiation cascade ( Figure S7 ). Taken together, these results raised the exciting possibility that VGF is impacting the OL lineage and contributes to the long-term survival of running cKO mice.
Adenoviral-Encoded Full-Length VGF Delivery
Increased Myelination and Prolonged the Lifespan of Snf2h-Null Ataxic Mice To determine whether VGF was sufficient to rescue the lifespan of cKO mice, we generated adenoviral (Ad) vectors expressing full-length mouse VGF protein (Ross and Parks, 2009 ). Control and sedentary cKO mice received tail vein injections at $P21 (1 3 10 12 viral particles/kg) and their survival was recorded. Strikingly, cKO mice that received the Ad-VGF injections were alive and healthy at P300 (time of analysis) whereas uninjected cKO or Ad-control (no VGF cDNA)-injected cKO mice perished between P25 and P45 using both C57Bl/6 and FVB/N backcrossed cKO strains ( Figure 7D ). Using qPCR to compare transcript levels between cKO Ad-control and cKO Ad-VGF, we were able to detect significant VGF mRNA upregulation in the heart, hippocampus, cerebellum, and brain stem, with highest levels in the liver, the primary site of adenoviral transduction (Figure 7E) . However, we only detected upregulation of the BDNF transcript in the brain (hippocampus, cerebellum, and brain stem) and not in any of the other tissues analyzed ( Figure 7E) . Importantly, TEM images demonstrated increased myelination in the molecular layer of the cerebellum and within the brain stem of cKO Ad-VGF-treated animals versus WT Ad-VGF-or cKO Ad-control-treated mice, suggesting that increasing cerebellar myelination was critical for the survival of the sedentary cKO mice (Figures 7F-7H) . Notably, we did observe some additional, but non-significant myelination in Ad-VGF-injected WT animals, but it was minimal compared to the rescued Ad-VGFtreated sedentary cKO mice. Moreover, we observed a significant increase in the number of NG2-BrdU and Olig2-BrdU double-positive cells in the cerebella of Snf2h cKO mice treated with Ad-VGF relative to all other treatments ( Figures 7I and 7J ). This was also accompanied by increased levels of the VGF propeptide in the plasma of cKO mice treated with Ad-VGF and not with Ad-CT ( Figure 7K ).
DISCUSSION
Exercise induces the secretion of several hundred peptides from skeletal muscle (myokines) that are known to exert autocrine, paracrine, and endocrine effects on multiple tissues, including the brain. Many of these myokines promote metabolic homeostasis and, collectively provide protective effects against obesity, diabetes, cardiovascular, and neurodegenerative disease (Pedersen and Febbraio, 2012; Pedersen et al., 2009) . Given the dependence of exercise on the long-term survival of Snf2h cKO mice, these systemic effects are key contributors to the recovery of these mice. In this regard, many studies have shown that exercise induces BDNF to promote neurogenesis, and exercise mimetics such as AICAR analogs and metformin similarly promote neurogenesis via BDNF (Dadwal et al., 2015; Kobilo et al., 2011; van Praag et al., 1999a van Praag et al., , 1999b van Praag et al., , 2005 Wang et al., 2012) . However, within the cerebellum we did not observe enhanced neurogenesis but rather increased oligodendrogenesis suggesting that the primary mechanism was distinct. Moreover, the comparative RNA-seq data indicated an upregulation of VGF, a neuropeptide precursor that: (1) is similarly induced by exercise within the hippocampus (Hunsberger et al., 2007) ; (2) has widespread influences on energy metabolism, antidepressant effects, neurogenesis, and learning (Bartolomucci et al., 2006; Hahm et al., 1999; Hunsberger et al., 2007; Thakker-Varia et al., 2007 ; and (3) it is highly expressed in OPs (Dugas et al., 2006) . Indeed, we demonstrated that VGF could induce oligodendrogenesis in vitro and that adenoviral delivery of the full-length VGF precursor could significantly rescue the survival of the Snf2h cKO mouse model and trigger de novo myelination of cerebellar neurons to ameliorate motor deficits and prolong their lifespan.
A key pending question is how does VGF impact the repair process in the Snf2h cKO mice? It is known that exercise induces VGF in the hippocampus and that this promotes the anti-depressant effects caused by running (Hunsberger et al., 2007; ThakkerVaria et al., 2007) . It also functions in a positive feedback loop to maintain BDNF expression (Hunsberger et al., 2007) . Studies on cultured hippocampal neurons have shown that VGF peptides stimulate multiple signaling cascades to enhance synaptic activity (Alder et al., 2003; Bozdagi et al., 2008) . Thus, within the cerebellum of the Snf2h cKO mice, the VGF peptides may serve to maintain the survival of the existing neurons and concomitantly, increase their synaptic activity, which would bolster cerebellar-dependent motor function. Consistent with this hypothesis, we observed increased expression of genes involved in serotonin, norepinephrine and dopamine synthesis, and enhanced dendritic arborization of PCs. Whether this is a direct or indirect effect of increased VGF expression requires further validation. Other studies have shown that BDNF released from astrocytes can also promote oligodendrogenesis (Miyamoto et al., 2015) . Surprisingly, we did not observe an effect of BDNF on our in vitro OP cultures, although we did observe increased BDNF levels in the brain following VGF adenoviral treatment of the mice. While we cannot explain our in vitro results, our in vivo data suggest that VGF may be able to stimulate astrocytes to release BDNF and promote oligodendrogenesis indirectly.
Neuronal damage and neuronal loss results in the recruitment of OPs and differentiation into OLs (Brousse et al., 2015; Piao et al., 2015) . Similarly, other studies have indicated that neuronal activity stimulates myelination to strengthen active circuits (Gibson et al., 2014) . Importantly, demyelinated axons are electrically active and can generate de novo synapses with recruited OPs to facilitate OL differentiation and repair (Gautier et al., 2015). Indeed, myelin is the most effective means of speeding conduction velocity by altering how electric potentials propagate. Most recently, cultured OPs were shown to preferentially myelinate electrically active axons, but OP-neuronal synapses were not required for activity-dependent myelination. One possible regulatory mechanism is through calcium signaling produced by vesicular release of glutamate, cellular effects that are also similarly mimicked by aerobic activity (Wake et al., 2015) . Because both OPs and neurons express VGF, one possibility is that OPs and neurons utilize VGF peptides as a secreted molecular tool to express their relative health or activity to the other cell, in synapse-dependent and independent manners. In this regard, reduced VGF is a biomarker for several neurodegenerative diseases, including ALS and Alzheimer's disease, and is also downregulated in human bipolar postmortem brain tissue (Ferri et al., 2011; Pasinetti et al., 2006; Selle et al., 2005; Thakker-Varia et al., 2010) . Moreover, the TLQP-21 peptide prevented apoptotic death of cerebellar granule neurons and exogenous induction of VGF in a mouse model of ALS attenuated excitotoxic injury, slowed disease progression, and prolonged survival (Severini et al., 2008; Shimazawa et al., 2010; Zhao et al., 2008) . We demonstrated that VGF peptides were capable of promoting OP proliferation and differentiation into OLs using primary mouse OP cultures. While the mechanism(s) remains to be elucidated, future studies using celltype-specific VGF cKO mice could shed light on whether VGF peptides function as secreted vehicles that mediate OL-neuron intercommunication to control activity-dependent synaptic remodeling and repair.
Inactivation of the Snf2h gene in the brain results in progressive cerebellar degeneration and death during early adulthood. Strikingly, voluntary running or intravenous full-length VGF delivery rescued the long-term survival of these animals (Figure 7L) . Taken together, our results suggest that damaged cerebellar neurons can be substantially rescued by increased myelination, utilizing an endogenous mechanism of brain repair. It is now clear that OPs are the largest population of dividing cells in the adult brain, hence intrinsically implicated in activity-dependent myelination of the postnatal brain. Additionally, white matter structure can change with environmental experience and functional activity (Zatorre et al., 2012) . In a normally functioning cerebellum, additional myelination is not as significant as in the pathological state, suggesting that exercise promotes a repair mechanism that counteracts a neurodegenerative process. How OP-neuron intercommunication changes during development in healthy and pathological states and in response to environmental stimuli are current areas of intense investigation. For the first time, our results provide strong evidence that VGF has the ability to stimulate OP proliferation, trigger myelination, revert neural damage, and prolong lifespan in our chosen disease model. These findings thereby illuminate a novel pathway to potentially treat other neuronal and/or oligodendroglia-associated pathologies of the CNS. 
Behavioral Analysis
All behavioral tests were completed in the Behavior Core Facility at the University of Ottawa using standardized protocols. Animals were habituated to the testing room at least $1 hr before testing. Behavioral assays were performed irrespective of sex. One-way ANOVA was used for at least 10-20 mice per genotype. The values are presented as the mean ± SEM. 
(legend continued on next page)
BrdU-Birthdating BrdU was diluted in nanopure water at a final concentration of 2 g/L and supplemented with 1% sucrose and protected from light. BrdU-containing water was changed with fresh stock every other day. Mice were given BrdU 2 days post-wheel introduction at P23 and allowed to drink freely for a maximum of 15 days (stopped at P40). Mice were then analyzed 50 days or 140 days post-BrdU removal (P90 or P180).
TSA and EdU Administration
Mice were single-housed and a running wheel was introduced between P21 and P25. TSA was administered intraperitoneally at 10 mg/kg at P30, and EdU was administered intraperitoneally the following day for 3 consecutive days at 100 mg/kg. Brains were analyzed at P40 and immunolabeled as described below. Cell counts were performed with the indicated markers from 1 mm 2 3 100 mm 3 confocal z stacks through the cerebellar lobes.
Immunofluorescent Histochemistry
Brain sections were obtained as 40-50 mm free-floating sections after cryopreservation. Sections were washed four times in PBS with 0.1% Triton X-100 (PBST), blocked (1 hr, room temperature [RT]) in 10% horse serum/ PBST, and incubated (overnight, 4 C) in primary antibodies. Primary and secondary antibodies are listed in the Supplemental Information.
Reverse Transcription and Quantitative Real-Time PCR Tissues were quickly dissected from mutant and control littermates and RNA was isolated using Trizol (Invitrogen) according to the manufacturer's instructions and further concentrated with RNeasy MinElute Cleanup Kits (QIAGEN). Glycogen (Ambion Life Technologies) was used as carrier. Total RNA (1 mg) was reverse-transcribed using SuperScriptIII (Invitrogen Life Technologies). cDNA was further diluted 1:10 and 1 ml was used per qPCR reaction. qPCRs were carried out using TaqMan probes (Applied Biosystems). Student's t test was used for statistical significance.
Western Blotting
Protein samples were resolved on SDS polyacrylamide gels under denaturing conditions or using Bis-Tris 4%-12% gradient gels (NuPage, Invitrogen) and blotted onto PVDF membranes (Immobilon-P; Millipore) by wet transfer for 1-2 hr at 90 V. Membranes were blocked (45 min, room temperature) with 5% skim milk in Tris-buffered saline containing 0.05% Triton X-100 (TBST), and incubated (4 C, overnight) with the following antibodies: rabbit anti-VGF (1:1,000; a kind gift from Dr. Stephen Salton) or mouse anti-b-Actin (1:30,000, Sigma). Western blots were quantitated using ImageJ software (rsbweb.nih.gov/ij/). At least three to five individual lanes from multiple litters were used for quantitation.
Cell Culture
Primary mouse oligodendrocyte precursor cells (OPCs) were harvested and propagated using an adaptation of the ''shake-off'' method originally described by McCarthy and de Vellis (1980) . In brief, neonatal mouse cortices were dissociated and seeded onto poly-L-lysine (PLL)-coated flasks and grown as a mixed glial culture for 10 days. OPCs were then detached from the mixed glial cell monolayer via orbital shaking, and the purified OPC population was seeded onto poly-D-lysine, PLL, or laminin-coated coverslips and differentiated for up to 6 days. For immunolabeling, OPCs were fixed with 3% paraformaldehyde (PFA) for 15 min at room temperature (RT) and washed in PBS (0.1 M). Cells were then permeabilized with a 0.1% Triton X-100 solution for 10 min at RT and subsequently washed in PBS. A 10% goat serum blocking solution was then applied for 40 min, followed by an overnight incubation (4 C) with primary antibodies diluted in blocking buffer: myelin- This OPC expansion and de novo myelination can also be mimicked with adenoviral-mediated full-length VGF precursor protein delivery in the absence of exercise. Upon running or VGF overexpression, ataxic Snf2h cKO mice show increased VGF protein in the plasma and brain, extensive myelination of damaged cerebella, improved motor function, and a significant extension of their lifespan. VGF, nerve growth factor-inducible; P, postnatal; cyan cell, OPC; yellow cell, neuron; light blue cell, mature oligodendrocyte. See also Figure S7 .
(Sigma-Aldrich, #B3795), or DMSO at 3 mM. Cells were then processed for immunofluorescence as described above.
RNA-Sequencing and Bioinformatics
Tissues were quickly dissected from mutant and control littermates and RNA was isolated using Trizol (Invitrogen) according to the manufacturer's instructions and further concentrated with RNeasy MinElute Cleanup Kits (QIAGEN). Glycogen (Ambion Life Technologies) was used as carrier. We pooled three independent cerebella as one sample per genotype and sequenced two independent pools per genotype using Illumina HiSeq 2000 paired-end technology at McGill University and Genome Quebec Innovation Center. Bioinformatics pipeline is described in the Supplemental Information.
Adenoviral Construction and Delivery
A plasmid containing the murine VGF cDNA (a kind gift of Stephen Salton, Mount Sinai School of Medicine), was digested with HindIII, the ends repaired with T4 DNA polymerase, digested with NotI, and the fragment cloned into EcoRV/NotI digested pRP2645 (Poulin et al., 2010) , generating pRP3137. As such, in pRP3137 full-length murine VGF was placed under regulation of the human cytomegalovirus immediate-early enhancer/promoter and bovine growth hormone polyadenylation sequence. The expression cassette contained in pRP3137 was cloned into an adenovirus type 5 genomic plasmid, pRP2014 (Poulin et al., 2010) , using RecA-mediated bacterial recombination, generating pRP3140 (Chartier et al., 1996; Ross and Parks, 2009 ). pRP3140 was transfected into HEK293 cells and then propagated and purified using standard techniques (Ross and Parks, 2009 ). Thus, AdRP3140 is an early region 1 (E1)/E3-deleted Ad vector containing the mVGF under regulation by the human CMV promoter and BGHpA. An empty adenoviral construct was used as control. Mice were given a single dose via tail injection of 1 3 10 12 viral particles per kilogram (VP/kg) diluted in a 100-mL final volume. At least 10-15 mice were injected per genotype per condition.
Image Acquisition and Processing
Tissue sections were examined and images captured using a Zeiss 510 laser scanning confocal microscope with UV (405 nm), argon (488 nm), helium/neon (546 nm), and helium/neon (633 nm) lasers. All images were acquired as 30 mm z stacks (in 1-to 2-mm intervals) and analyzed as projections using the LSM 510 Image Browser software (Zeiss). Images were exported to Adobe Photoshop CS5 (Adobe Systems) and further processed for contrast when necessary.
Toluidine Blue Staining
Semi-thin sections of 0.5 mm were stained with 1% toluidine blue and 2% Borate in distilled water. Histological samples were scanned with a MIRAX MIDI automated scanning light microscope (Zeiss) and images processed with Zeiss MIRAX Viewer software (Zeiss).
Transmission Electron Microscopy
Cerebella vermis, deep cerebellar nuclei, brain stem, and inferior olive brain regions were collected under a stereomicroscope, cut into sections of 1-to 2-mm thickness and fixed for at least 4 hr to overnight in Karnovsky's fixative (4% paraformaldehyde, 2% glutaraldehyde, and 0.1 M cacodylate in PBS [pH 7.4]) at 4 C. Grids were stained with 2% aqueous uranyl acetate and with Reynold's lead citrate. Sections were observed under a transmission electron microscope (TEM) (Hitachi 7100). All ultrastructural analysis were based on at least three mice per genotype of the same age for each group examined.
Statistics
Group statistical analysis was performed via a two-tailed Student's t test or one-way ANOVA where indicated; p < 0.05 was accepted as statistically significant. At least three mice from each genotype were used for evaluation. The values are presented as the mean ± SEM. For BrdU or EdU cell counting in the cerebellar lobes and brain stem, three 1-mm 2 regions in 100 mm 3 cubic z stacks were counted per animal, n = 4 mice per genotype.
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